Literature DB >> 24910251

Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study.

Maj Rabjerg1, Minne Nedergaard Mikkelsen, Steen Walter, Niels Marcussen.   

Abstract

On the basis of associations between tumor size, pathological stage, histological subtype and tumor grade in incidentally detected renal cell carcinoma vs symptomatic renal cell carcinoma, we discussed the need for a screening program of renal cell carcinoma in Denmark. We analyzed a consecutive series of 204 patients with renal tumors in 2011 and 2012. The tumors were classified according to detection mode: symptomatic and incidental and compared to pathological parameters. Eighty-nine patients (44%) were symptomatic, 113 (55%) were incidental. Information was not available in two patients. In the incidental group, the size (p<0.05), pathological stage (p<0.001), Fuhrman grading (p<0.0001) and Leibovich score (p<0.0001) were lower than in those causing symptoms. Significantly less in the incidental group had metastasis at follow-up (p<0.0001). Incidentally discovered RCC constitute a major part of kidney tumors. They have a more favorable prognosis than symptomatic tumors and seem to be discovered in an earlier phase. Needle core biopsy is an accurate technique for distinguishing between malignant and benign tumors and is recommendable for smaller incidental tumors. Screening may help detect RCC at an earlier stage.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Incidental; renal cell carcinoma; screening

Mesh:

Year:  2014        PMID: 24910251     DOI: 10.1111/apm.12282

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  16 in total

1.  Renal cancer at unenhanced CT: imaging features, detection rates, and outcomes.

Authors:  Stacy D O'Connor; Stuart G Silverman; Laila R Cochon; Ramin K Khorasani
Journal:  Abdom Radiol (NY)       Date:  2018-07

2.  Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?

Authors:  Erik Rud; Kristina Flor Galtung; Peter Mæhre Lauritzen; Eduard Baco; Tove Flatabø; Gunnar Sandbæk
Journal:  Eur Radiol       Date:  2019-11-20       Impact factor: 5.315

3.  Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.

Authors:  Levente Kuthi; Alex Jenei; Adrienn Hajdu; István Németh; Zoltán Varga; Zoltán Bajory; László Pajor; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2016-12-28       Impact factor: 3.201

4.  The value of surveying the kidneys during pelvic ultrasound examinations.

Authors:  Orlaith Brennan; Sheila Oh; Martin Necas
Journal:  Australas J Ultrasound Med       Date:  2019-01-23

Review 5.  Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?

Authors:  Francesco Trevisani; Matteo Floris; Riccardo Vago; Roberto Minnei; Alessandra Cinque
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

6.  Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2015-03-07

Review 7.  Current evidence on screening for renal cancer.

Authors:  Juliet Usher-Smith; Rebecca K Simmons; Sabrina H Rossi; Grant D Stewart
Journal:  Nat Rev Urol       Date:  2020-08-28       Impact factor: 16.430

Review 8.  The Past, Present, and Future in Management of Small Renal Masses.

Authors:  Sarah C Ha; Haley A Zlomke; Nicholas Cost; Shandra Wilson
Journal:  J Oncol       Date:  2015-09-30       Impact factor: 4.375

9.  Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014.

Authors:  Tao Bai; Li Wang; Dongwen Wang; Xiaobin Yuan; Wei Bai; Qin Yang; Xian Yang
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

Review 10.  Epidemiology and screening for renal cancer.

Authors:  Sabrina H Rossi; Tobias Klatte; Juliet Usher-Smith; Grant D Stewart
Journal:  World J Urol       Date:  2018-04-02       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.